Uncategorized
How to Make Your Clinical Trial the Trial of Choice: When You Want to Get to Market Faster, Meeting Every Milestone Matters.
By: Reverba Clinical Partnerships Team From first patient/first dose to data lock, everything depends on recruiting and retaining clinical trial participants. That can be quite challenging. A 2022 editorial in Clinical Trials Arena noted that the biggest reason for trial termination is low accrual rates which have accounted for 25.4% of all terminated trials. The good…
Read MoreClinical Trials Day: May 20th
Today is Clinical Trials Day –a day where clinical trial awareness is raised and we honor clinical research professionals across the globe. In tribute, we are pleased to showcase a recent article in MedCityNews where a Health Stories Project® research study was cited, revealing that 97% of patients believe that their voice is key for…
Read MoreKnock Down Internal Silos and Add More Value To The Patient Voice
By: Jean McCoy EVP Reverba Partnerships When it comes to listening to patients, clinical and consumer marketing tends to remain in separate silos. But incorporating the patient voice can make a positive impact at every point from pre-clinical development through commercialization and post-marketing. Doing so can help companies align their goals and programs with patients’…
Read MoreHealth Perspectives Group becomes Reverba
Entering the company’s 20th year, this new chapter represents the next level of transformativetech-enabled patient engagement for the biopharmaceutical industry – SEATTLE – November 10, 2021 – Health Perspectives Group, a leader in patient engagement, today announced its name change to Reverba. The name change reflects the firm’s evolution into a new type of global…
Read More